A comparison of HMGB1 concentrations between cerebrospinal fluid and blood in patients with neurological disease

References

• Altiokka-Uzun, G., et al., 2015. Oligoclonal bands and increased cytokine levels in idiopathic intracranial hypertension. Cephalalgia, 35 (13), 1153–1161.
   PubMed Web of Science ®Google Scholar
• Andersson, U., Antoine, D.J., and Tracey, K.J., 2014. The functions of HMGB1 depend on molecular localization and post-translational modifications. Journal of internal medicine, 276, 420–424.
   PubMed Web of Science ®Google Scholar
• Andreasen, N., et al., 2001. Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. Archives of neurology, 58, 373–379.
   PubMed Web of Science ®Google Scholar
• Anoop, A., et al., 2010. CSF Biomarkers for Alzheimer’s disease diagnosis. International journal of Alzheimer’s disease, 2010, 606802. doi: 10.4061/2010/606802.
   PubMedGoogle Scholar
• Antoine, D.J., et al., 2013. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology, 58, 777–787.
   PubMed Web of Science ®Google Scholar
• Asano, T., et al., 2011. High mobility group box 1 in cerebrospinal fluid from several neurological diseases at early time points. International Journal of neuroscience, 121, 480–484.
   PubMed Web of Science ®Google Scholar
• Babaloo, Z., et al., 2015. The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: interleukin-17A and interleukin-17F serum levels. Immunology letters, 164, 76–80.
   PubMed Web of Science ®Google Scholar
• Balasa, R., Bajko, Z., and Hutanu, A., 2013. Serum levels of IL-17A in patients with relapsing-remitting multiple sclerosis treated with interferon-β. Multiple sclerosis journal, 19, 885–890.
   PubMed Web of Science ®Google Scholar
• Bauer, J., Bien, C.G., and Lassmann, H., 2002. Rasmussen’s encephalitis: a role for autoimmune cytotoxic T lymphocytes. Current opinion neurology, 15, 197–200.
   PubMed Web of Science ®Google Scholar
• Bien, C.G., et al., 2002. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen’s encephalitis. Annals of neurology, 51, 311–318.
   PubMed Web of Science ®Google Scholar
• Borroni, B., et al., 2010. Blood cell markers in Alzheimer disease: amyloid precursor protein form ratio in platelets. Experimental gerontology, 45, 53–56.
   PubMed Web of Science ®Google Scholar
• Chen, C.G., et al., 2013. Clinical significance of serum high-mobility group box 1 detection in esophageal squamous cell carcinoma. Zhonghua Wei Chang Wai Ke Za Zhi, 16, 838–841.
   PubMedGoogle Scholar
• Cirillo, P., et al., 2009. Increased high mobility group box-1 protein levels are associated with impaired cardiopulmonary and echocardiographic findings after acute myocardial infarction. Journal of cardiac failure, 15, 362–367.
   PubMed Web of Science ®Google Scholar
• Corbett, J.J. and Mehta, M.P., 1983. Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology, 33, 1386–1388.
   PubMed Web of Science ®Google Scholar
• Dhungana, S., Sharrack, B., and Woodroofe, N. 2009a. Cytokines and chemokines in idiopathic intracranial hypertension. Headache, 49, 282–285.
   PubMed Web of Science ®Google Scholar
• Dhungana, S., Sharrack, B., and Woodroofe, N. 2009b. IL-1beta, TNF and IP-10 in the cerebrospinal fluid and serum are not altered in patients with idiopathic intracranial hypertension compared to controls. Clinical endocrinology (Oxford), 71, 896–897.
   PubMed Web of Science ®Google Scholar
• Edwards, L.J., et al., 2013. Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension. American journal of clinical and experimental immunology, 2, 234–244.
   PubMedGoogle Scholar
• Fahmueller, Y.N., et al., 2013. Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients. International journal of cancer, 132, 2349–2358.
   PubMed Web of Science ®Google Scholar
• Fukami, A., et al., 2009. Factors associated with serum high mobility group box 1 (HMGB1) levels in a general population. Metabolism, 58, 1688–1693.
   PubMed Web of Science ®Google Scholar
• Gekakis, N., et al., 1998. Role of the CLOCK protein in the mammalian circadian mechanism. Science, 280, 1564–1569.
   PubMed Web of Science ®Google Scholar
• Goldstein, R.S., et al., 2006. Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock, 25, 571–574.
   PubMed Web of Science ®Google Scholar
• Griffiths, M.J., et al., 2012. In enterovirus 71 encephalitis with cardio-respiratory compromise, elevated interleukin 1beta, interleukin 1 receptor antagonist, and granulocyte colony-stimulating factor levels are markers of poor prognosis. The journal of infectious diseases, 206, 881–892.
   PubMed Web of Science ®Google Scholar
• Guidelines N. 2012. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care [Online]. Available from: http://www.nice.org.uk/guidance/cg137/chapter/appendix-f-protocols-for-treating-convulsive-status-epilepticus-in-adults-and-children-adults [Accessed 23 February 2015].
   Google Scholar
• Hansson, O., et al., 2006. Association between CSF biomarkers and incipient Alzheimer’s disease in patients with mild cognitive impairment: a follow-up study. Lancet neurology, 5, 228–234.
   PubMed Web of Science ®Google Scholar
• Hashimoto, T., et al., 2012. Circulating high-mobility group box 1 and cardiovascular mortality in unstable angina and non-ST-segment elevation myocardial infarction. Atherosclerosis, 221, 490–495.
   PubMed Web of Science ®Google Scholar
• Hohne, C., et al., 2013. High mobility group box 1 prolongs inflammation and worsens disease in pneumococcal meningitis. Brain, 136, 1746–1759.
   PubMed Web of Science ®Google Scholar
• Huber, A.K., et al., 2014. Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS. Neurology, 83, 1500–1507.
   PubMed Web of Science ®Google Scholar
• Ichiyama, T., et al., 1997. Levels of transforming growth factor beta 1, tumor necrosis factor alpha, and interleukin 6 in cerebrospinal fluid: association with clinical outcome for children with bacterial meningitis. Clinical infectious diseases, 25, 328–329.
   PubMed Web of Science ®Google Scholar
• Johansson, P., et al., 2011. Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population. Journal of Alzheimer’s disease, 24, 537–546.
   PubMed Web of Science ®Google Scholar
• Klein, M., et al., 2008. Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4. The journal of infectious diseases, 198, 1028–1036.
   PubMed Web of Science ®Google Scholar
• Landau, S.M., et al., 2010. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology, 75, 230–238.
   PubMed Web of Science ®Google Scholar
• Luchtman, D.W., et al., 2014. IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: current and future developments. Cytokine and growth factor reviews, 25, 403–413.
   PubMed Web of Science ®Google Scholar
• Mustafa, M.M., et al., 1989. Correlation of interleukin-1 beta and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. Journal of pediatrics, 115, 208–213.
   PubMed Web of Science ®Google Scholar
• Ohga, S., et al., 1994. Cerebrospinal fluid concentrations of interleukin-1 beta, tumour necrosis factor-alpha, and interferon gamma in bacterial meningitis. Archives of disease in childhood, 70, 123–125.
   PubMed Web of Science ®Google Scholar
• Price, R.W., et al., 2013. Approach to cerebrospinal fluid (CSF) biomarker discovery and evaluation in HIV infection. Journal of neuroimmune pharmacology, 8, 1147–1158.
   PubMed Web of Science ®Google Scholar
• Rasmussen, T., Olszewski, J., and Lloydsmith, D., 1958. Focal seizures due to chronic localized encephalitis. Neurology, 8, 435–445.
   PubMed Web of Science ®Google Scholar
• Redzic, Z. 2011. Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences. Fluids barriers CNS, 8, 3.
   PubMedGoogle Scholar
• Sakka, L., Coll, G., and Chazal, J., 2011. Anatomy and physiology of cerebrospinal fluid. European annals of otorhinolaryngology head and neck diseases, 128, 309–316.
   PubMed Web of Science ®Google Scholar
• Schiraldi, M., et al., 2012. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. Journal of experimental medicine, 209, 551–563.
   PubMed Web of Science ®Google Scholar
• Schwerk, C., et al., 2012. Polar invasion and translocation of Neisseria meningitidis and Streptococcus suis in a novel human model of the blood-cerebrospinal fluid barrier. PLoS One, 7, e30069.
   PubMed Web of Science ®Google Scholar
• Segal, M.B. 1993. Extracellular and cerebrospinal fluids. Journal of inherited metabolic disease, 16, 617–638.
   PubMed Web of Science ®Google Scholar
• Sinclair, A.J., et al., 2008. Exploring the pathogenesis of IIH: an inflammatory perspective. Journal of neuroimmunology, 201–202, 212.
   PubMed Web of Science ®Google Scholar
• Spector, R., et al., 2015a. A balanced view of choroid plexus structure and function: focus on adult humans. Experimental neurology, 267, 78–86.
   PubMed Web of Science ®Google Scholar
• Spector, R., Robert Snodgrass, S., and Johanson, C.E., 2015b. A balanced view of the cerebrospinal fluid composition and functions: focus on adult humans. Experimental neurology, 273, 57–68.
   PubMed Web of Science ®Google Scholar
• Tabata, C., et al., 2013a. Serum HMGB1 as a diagnostic marker for malignant peritoneal mesothelioma. Journal of clinical gastroenterology, 47, 684–688.
   PubMed Web of Science ®Google Scholar
• Tabata, C., et al., 2013b. Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma. BMC cancer, 13, 205.
   PubMed Web of Science ®Google Scholar
• Tang, D., et al., 2008. A pilot study to detect high mobility group box 1 and heat shock protein 72 in cerebrospinal fluid of pediatric patients with meningitis. Critical care medicine, 36, 291–295.
   PubMed Web of Science ®Google Scholar
• Uzawa, A., et al., 2013. CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica. Journal of neurology neurosurgery psychiatry, 84, 517–522.
   PubMed Web of Science ®Google Scholar
• Wang, H., et al., 2013. Cerebrospinal fluid high-mobility group box protein 1 in neuromyelitis optica and multiple sclerosis. Neuroimmunomodulation, 20, 113–118.
   PubMed Web of Science ®Google Scholar
• Woodbury, L.A., and Davenport, V.D., 1952. Design and use of a new electroshock seizure apparatus, and analysis of factors altering seizure threshold and pattern. Archives international pharmacodynmic theory, 92, 97–107.
   PubMedGoogle Scholar